Aspirin halved colorectal cancer in Lynch syndrome in a 861-patient RCT
Louis shares a BBC article describing Burn's 2020 trial of 861 Lynch syndrome patients: 600 mg daily aspirin for at least two years roughly halved colorectal cancer risk over 10 years, with a follow-up trial of lower dose pending.




